Insights

More Articles Back to Article

J&J finishes enrollment for Phase 3 COVID-19 vaccine trials

Johnson & Johnson has fully enrolled the late-stage trials for its COVID-19 vaccine candidate with 45,000 participants. The company also disclosed that the vaccine has the potential to be given in one injection and will not require ultra-cold storage. WBTS-TV (Boston) (12/20)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!